US 12241064
REVERSIR™ compounds
granted A61PA61P43/00
Quick answer
US patent 12241064 (REVERSIR™ compounds) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P43/00